Son Mai
Family · Riverdale, GANPI 1174136071
Payments from drug & device makers
Across 97 payments — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$403
- Novo Nordisk$300
- Lilly USA, LLC$160
- Bayer$123
- Astellas Pharma US Inc$122
- Sumitomo Pharma America, Inc.$110
- plus $723 from 12 others
What the payments were for
- Food & beverage$1,85596%
- Education$854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $403 |
| Novo Nordisk | 16 | $300 |
| Lilly USA, LLC | 9 | $160 |
| Bayer | 6 | $123 |
| Astellas Pharma US Inc | 4 | $122 |
| Sumitomo Pharma America, Inc. | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $106 |
| Amgen | 6 | $105 |
| Exact Sciences | 5 | $84 |
| AstraZeneca | 4 | $79 |
| GSK | 4 | $78 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $64 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Biohaven Pharmaceuticals, Inc. | 2 | $41 |
| Boehringer Ingelheim | 2 | $38 |
| Radius Health, Inc. | 2 | $36 |
| Amarin Pharma, Inc. | 1 | $24 |
| Gilead | 1 | $23 |
How this compares
$1,940 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 124 | $128,707 |
| JardianceEmpagliflozin | 73 | $127,567 |
| OzempicSemaglutide | 54 | $83,489 |
| EliquisApixaban | 68 | $75,964 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 71 | $74,999 |
| TrulicityDulaglutide | 32 | $62,029 |
| FarxigaDapagliflozin Propanediol | 37 | $59,839 |
| RybelsusSemaglutide | 28 | $58,021 |
| JanuviaSitagliptin Phosphate | 32 | $54,149 |
| Metformin Er GastricMetformin Hcl | 55 | $54,052 |
| MyrbetriqMirabegron | 48 | $48,672 |
| ProliaDenosumab | 25 | $43,735 |
| Diclofenac Epolamine | 28 | $43,605 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 31 | $30,069 |
| MounjaroTirzepatide | 14 | $29,544 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Restasis | $403 | $146,884136 claims |
| Novo NordiskOzempic, Rybelsus | $300 | $141,51082 claims |
| Boehringer IngelheimJardiance | $38 | $127,56773 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $79 | $95,59981 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $160 | $91,57346 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $78 | $85,52891 claims |
| Astellas Pharma US IncMyrbetriq | $122 | $48,67248 claims |
| AmgenProlia | $105 | $43,73525 claims |
| BayerKerendia | $123 | $23,68512 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $110 | $18,42417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.
Other family in Riverdale
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.